| Respiratory System |
Prescribing Data Report |
July 2021 |
| Inhaler Carbon Impact Assessment Tool |
Prescribing Data Report |
July 2021 |
| Inhaler carbon footprint; significance, focus & action |
Prescribing for Population Health |
January 2021 |
| Comparison of LAMA/LABA inhalers (update February 2021) |
Prescriber Support Tools |
February 2021 |
| Comparison of oscillating positive expiratory pressure devices |
Prescriber Support Tools |
August 2019 |
| Fluticasone, umeclidinium, and vilanterol (Trelegy Ellipta) for COPD |
New Drug Evaluations |
May 2018 |
